Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus

Diabetic Medicine

Volumn 16, Issue 5, 1999, Pages 373-383

  Björntorp, Per ^a   Holm, G ^b   Rosmond, R ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Central obesity; Dyslipidaemia; HPA axis; Hypertension; Hypothalamus; Insulin resistance; Metabolic syndrome; Type 2 diabetes mellitus

Indexed keywords

ARTICLE; COMORBIDITY; ENVIRONMENTAL FACTOR; FEEDBACK SYSTEM; GENETIC SUSCEPTIBILITY; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; NERVE CELL PLASTICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; STRESS;

ADULT; AROUSAL; DIABETES MELLITUS, TYPE 2; FEEDBACK; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; REFERENCE VALUES;

EID: 0032706949     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00067.x     Document Type: Article

References (77)

1. 1 Anonymous. Obesity. Preventing and managing the global epidemic 1998. Report of a WHO Consultation on Obesity, Geneva, 3-5 June 1997. WHO/NUT/NCD/981.
2. 2 Ohlsson L-O, Larsson B, Svärdsudd K, Welin L, Eriksson H, Wilhelmsen L et al. The influence of body fat distribution on the incidence of diabetes mellitus. A 13,5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985; 34: 1055-1058.
3. 3 Bergstrom RW, Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY. Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with the development of NIDDM in Japanese-American men. Diabetes 1990; 39: 104-111.
4. 4 Björntorp P, Visceral Obesity. A 'civilization syndrome'. Obes Res 1993; 1: 206-222.
5. 5 Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994; 73: 761-811.
6. 6 Groop L, Lehto M, Orho M. Non-insulin dependent diabetes mellitus: a genetic and metabolic nightmare. Diab Nutr Metab 1994; 7: 253-261.
7. 7 Björntorp P. Abdominal obesity and the development of non-insulin dependent diabetes mellitus. Diab/Metab Rev 1988; 4: 615-622.
8. 8 Björntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991; 14: 1132-1143.
9. 9 Björntorp P. Possible mechanisms relating fat distribution and metabolism. In: Bouchard C Johnston F, eds. Fat Distribution During Growth and Later Health Outcomes. New York: Alan R Liss, 1988: 175-191.
10. 10 Mårin P, Darin N, Amemiya T, Andersson B, Jern S, Björntorp P. Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 1992; 41: 882-886.
11. 11 Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R et al. The hypothalamo-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab 1993; 77: 341-346.
12. 12 Kirschbaum G, Hellhammer DH. Salivary Cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 1994; 19: 313-333.
13. 13 Laudat MH, Cerdas S, Fournier C, Guiban D, Guilhaume B, Luton JP. Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function. J Clin Endocrinol Metab 1988; 66: 343-348.
14. 14 Rosmond R, Holm G, Björntorp P. Cortisol secretion and the metabolic syndrome. Obes Res 1999 (in press).
15. 15 Rosmond R, Dallman MF, Björntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998; 83: 1853-1859.
16. 16 Ljung T, Andersson B, Bengtsson B-Å, Björntorp P, Mårin P. Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study. Obes Res 1996; 4: 277-282.
17. 17 Clemmons DR, Van Wyk JJ. Factors controlling blood concentration of somatomedin C. Clin Endocrinol Metab 1984; 13: 113-143.
18. 18 Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
19. 19 McEwen B, Cameron H, Chao HM, Gould E, Magarinos AM, Watanabe Y et al. Adrenal steroids and plasticity of hippocampal neurons: toward an understanding of underlying cellular and molecular mechanisms. Cell Mol Neurobiol 1993; 13: 457-482.
20. 20 Starkman MN, Sebarski SS, Berent S, Schteingardt DE. Hippocampal volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatr 1992; 32: 756-765.
21. 21 Yehuda R, Giller EL, Southwick SM, Lowry MT, Mason JW. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic disorder. Biol Psychiatr 1991; 30: 1031-1048.
22. 22 Smyth J, Ockenfels MC, Porter L, Kirschbaum C, Hellhammer DH, Stone AA. Stressors and mood measured on a momentary basis are associated with salivary cortisol secretion. Psychoneuroendocrinology 1998; 23: 353-370.
23. 23 Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. J Med Am Assoc 1992; 267: 1244-1252.
24. 24 Mayo-Smith W, Hayes CW, Biller BMK, Klibanski A, Rosenthal H, Rosenthal DI. Body fat distribution measured with CT. Correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. Radiology 1989; 170: 515-518.
25. 25 Lönn L, Kvist L, Ernest I, Sjöström L. Changes in body composition and adipose tissue distribution after treatment of women with Cushing's syndrome. Metabolism 1994; 43: 1517-1522.
26. 26 Björntorp P. Review: The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 1996; 20: 291-302.
27. 27 Bajalska JJ, Kumar S, Stewart PM. Does central obesity reflect 'Cushing's disease of the omentum'? Lancet 1997; 349: 1210-1213.
28. 28 Amatruda IM, Livingston JN, Lockwood DH. Cellular mechanisms of selected states of insulin resistance: human obesity, glucocorticoid excess and chronic renal failure. Diabetes Metab Rev 1985; 3: 293-317.
29. 29 Seidell JC, Björntorp P, Sjöström L, Kvist H, Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose and C-peptide levels, but negatively with testosterone levels. Metabolism 1990; 39: 897-901.
30. 30 Mårin P, Krotkiewski M, Björntorp P. Androgen treatment of middle-aged, obese men: Effects on metabolism, muscle and adipose tissues. Eur J Int Med 1992; 1: 329-336.
31. 31 Tibblin G, Adlerberth A, Lindstedt G, Björntorp P. The pituitary-gonadal axis and health in elderly men. A study of men born in 1913. Diabetes 1996; 45: 1605-1609.
32. 32 Holmäng A, Björntorp P. The effects of testosterone on insulin sensitivity in male rats. Acta Phys Scand 1992; 146: 505-510.
33. 33 Björntorp P. Androgens, the metabolic syndrome and non-insulin dependent diabetes mellitus. Ann N Y Acad Sci 1993; 676: 242-252.
34. 34 Taborsky GJ Jr, Havel PJ, Porte D Jr. Stress-induced activation of the neuroendocrine system and its effects on carbohydrate metabolism. In: Porte D Jr, Sherwin RS, eds. Ellenberg and Rifkin's Diabetes Mellitus. Connecticut: Appleton & Lange, Stamford, 1997: 141-168.
35. 35 Bengtsson B-Å, Edén S, Lönn L, Kvist H, Stokland A, Lindstedt G et al. Treatment of adults with growth hormone deficiency with recombinant human growth hormone. J Clin Endocrinol Metab 1993; 76: 309-317.
36. 36 Johannsson G, Mårin P, Lönn L, Ottosson M, Stenlöf K, Björntorp P et al. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab 1997; 82: 727-734.
37. 37 Jensen M, Haymond M, Rizza R, Cryer P, Miles J. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989; 83: 1168-1173.
38. 38 Rebuffé-Scrive M, Andersson B, Olbe L, Björntorp P. Metabolism of adipose tissue in intraabdominal depots of non-obese men and women. Metabolism 1989; 38: 453-458.
39. 39 Rebuffé-Scrive M, Anderson B, Olbe L, Björntorp P. Metabolism of adipose tissue in intraabdominal depots in severely obese men and women. Metabolism 1990; 39: 1021-1025.
40. 40 Arner P. Difference in lipolysis between human subcutaneous and omental adipose tissue. Ann Med 1995; 27: 435-438.
41. 41 Mårin P, Andersson B, Ottosson M, Olbe L, Chowdhury B, Kvist H et al. The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism 1992; 41: 1242-1248.
42. 42 Lönnqvist F, Krief S, Strosberg AD, Nyberg B, Emorine LJ, Arner P. Evidence for a functional β-3 receptor in man. Brit J Pharmacol 1993; 110: 929-936.
43. 43 Cigolini M, Smith U. Human adipose tissue in culture. VIII. Studies on the insulin-antagonistic effect of glucocorticoids. Metabolism 1979; 28: 502-510.
44. 44 Rebuffé-Scrive M, Brönnegard M, Nilsson A, Eldh J, Gustafsson J, Björntorp P. Steroid hormone receptors in human adipose tissues. J Clin Endocrinol Metab 1990; 71: 1215-1219.
45. 45 Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HH, Kral JG. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord 1995; 19: 846-850.
46. 46 Goto T, Oumua T, Takebe K, Kral JG. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 1995; 19: 841-845.
47. 47 Björntorp P. 'Portal' adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990; 10: 493-496.
48. 48 Krieger DR, Landsberg L. Mechanisms in obesity-related hypertension: role of insulin and catecholamines. Am J Hypertens 1988; 1: 84-90.
49. 49 DeFronzo RA, Cooke CR, Andres R, Falcona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium and phosphate in man. J Clin Invest 1975; 55: 845-855.
50. 50 Hall JE, Brands MW, Zappe DH, Alonso Galicia M. Insulin resistance, hyperinsulinemia, and hypertension: causes, consequences, or merely correlations? Proc Soc Exp Biol Med 1995; 208: 317-329.
51. 51 Rosmond R, Björntorp P. Blood pressure in relation to obesity, insulin and the hypothalamic-pituitary-adrenal axis in Swedish men. J Hypertens 1998; 16: 1721-1726.
52. 52 Folkow B. Stress, hypothalamic function and neuroendocrine consequences. Acta Med Scand 1987; 723: 61-69.
53. 53 Julius S, Esler MD, Randall OS. Role of autonomic nervous system in mild human hypertension. Clin Sci Mol Med 1975; 48: 243-252.
54. 54 Ljung T, Thorén P, Mårin P, McEwen BS, Dallman MF, Björntorp P. The sympathetic nervous system in men with abdominal obesity. Int J Obes 1999 (in press).
55. 55 Frankenhaeuser M. The sympathetic-adrenal and pituitary-adrenal response to challenge: comparison between the sexes. In: Dembroski TM, Schmidt TH, Blümchen G, eds. Biobehavioral Bases of Coronary Heart Disease, Human Psychophysiology. Basel: S. Karger, 1983:91-105.
56. 56 Richard D. Involvement of corticotropin-releasing factor in the control of food intake and energy expenditure. Ann N Y Acad Sci 1993; 697: 155-172.
57. 57 Rosmond R, Björntorp P. The interactions between hypothalamic-pituitary-adrenal axis activity, testosterone, insulin-like growth factor I and abdominal obesity with metabolism and blood pressure in men. Int J Obes 1998; 22: 1184-1196.
58. 58 Zahrzewska KE, Cusin J, Sainbury A, Rohner-Jeanrenaud F, Jeanrenaud B. Glucocorticoids are counterregulatory hormones of leptin. Towards an understanding of leptin resistance. Diabetes 1997; 46: 717-719.
59. 59 Tsigos C, Young RJ, White A. Diabetic neuropathy is associated with increased acticity of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 1993; 76: 554-558.
60. 60 Surwit RS, Feinglos MN. The effect of relaxation on glucose tolerance in non-insulin dependent diabetes mellitus. Diabetes Care 1983; 7: 203-204.
61. 61 Surwit RS, McCubbin JA, Kuhn JA, McGee CM, Gerstenfeld D, Feinglos MN. Alprazolam reduces stress hyperglycemia in ob/ob mice. Psychosom Med 1986; 48: 278-282.
62. 62 Lapidus L, Bengtsson C, Hällström T, Björntorp P. Obesity, adipose tissue distribution and health in women. Results from a population study in Gothenburg, Sweden. Appetite 1989; 12: 25-35.
63. 63 Rosmond R, Lapidus L, Mårin P, Björntorp P. Mental distress, obesity and body fat distribution in middle-aged men. Obes Res 1996; 4: 245-252.
64. 64 Rosmond R, Lapidus L, Björntorp P. The influence of occupational and social factors on obesity and body fat distribution in middle-aged men. Int J Obes Relat Metab Disord 1996; 20: 599-607.
65. 65 Rosmond R, Björntorp P. Psychiatric ill-health of women and its relationship to obesity and body fat distribution. Obes Res 1998; 6: 338-345.
66. 66 Henry J, Stephens P. Stress, health, and the social environment. A Sociobiological Approach to Medicine. New York: Springer-Verlag 1977.
67. 67 Jayo JM, Shively CA, Kaplan JR, Manuck SB. Effects of exercise and stress on body fat distribution in male Cynomolgus monkeys. Int J Obes Relat Metab Disord 1993; 17: 597-604.
68. 68 Shively CA, Laber-Laird K, Anton RF. Behavior and physiology of social stress and depression in female Cynomolgus monkeys. Biol Psychiatry 1997; 41: 871-882.
69. 69 Linkowski P, Van Onderbregen A, Kerkhofs M, Bosson D, Mendlewicz J, Van Cauter E. Twins study of the 24-h cortisol profile: evidence for genetic control of the human circadian clock. Am J Physiol 1993; 264: 173-181.
70. 70 Bouchard C, Pérusse L. Current status of the human obesity gene map. Obes Res 1996; 4: 81-90.
71. 71 Weaver JU, Hitman GA, Kopelman PG. An association between a Bcl 1 restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinemia in obese women. J Mol Endocrinol 1992; 9: 295-300.
72. 72 Buemann B, Vohl M-C, Chagnon M, Chagnon YC, Gagnon J, Pérusse L et al. Abdominal sceral fat is associated with a Bcl 1 restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes Res 1997; 5: 186-192.
73. 73 Després JP, Pouliot MC, Moorjani S, Nadeau A, Tremblay A, Lupien PJ et al. Loss of abdominal fat and metabolic response to exercise training in obese women. Am J Physiol 1991; 261: 159-167.
74. 74 Björntorp P, de Jounge K, Sjöström L, Sullivan L. The effect of physical training on insulin production in obesity. Metabolism 1970; 19: 631-638.
75. 75 Anonymous. Physical activity and health: A Report of the Surgeon General. Washington DC: US Department of Health and Human Services, 1996.
76. 76 Ottosson M, Mårin P, Karason K, Elander A, Björntorp P. Blockade of the glucocorticoid receptor with RU 486: Effects in vitro and in vivo on human adipose tissue lipoprotein lipase activity. Obes Res 1995; 3: 233-240.
77. 77 York DA. Genetic models of animal obesity. In: Björntorp P, Brodoff BN, eds. Obesity. Philadelphia: JB Lippincott, 1992: 233-240.